STE31 Revenue first quarter 2023 Y/Y Growth Comment
Steris Plc achieved in the first quarter 2023, above Company average Revenue growth of 23.29% year on year, to $ 1,492.70 millions.
Looking into first quarter 2023 results within Medical Equipment & Supplies industry 68 other companies have achieved higher Revenue growth. While Steris Plc' s Revenue rise of 23.29% ranks overall at the positon no. 2141 in the first quarter 2023.
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023
Steris Plc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
23.6 %
3.49 %
-18.72 %
(Sep 30 2021)
STE31's I. Quarter Q/Q Revenue Comment
Steris Plc achieved in the I. Quarter 2023 above company average sequential Revenue jump of 34.18%, to $ 1,492.70 millions, from $1,112.43 millions in the fourth quarter. STE31 is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 825.
Steris Plc achieved in the I. Quarter 2023 above company average sequential Revenue jump of 34.18%, to $ 1,492.70 millions, from $1,112.43 millions in the fourth quarter. STE31 is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 825.
Steris Plc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Dec 31 2022)
12 Months Ending (Sep 30 2022)
12 Months Ending (Jun 30 2022)
12 Months Ending (Mar 31 2022)
12 Months Ending (Dec 31 2021)
Cumulative Revenue 12 Months Ending
$ 4,465.70
$ 4,562.24
$ 4,668.29
$ 4,585.06
$ 4,247.91
Y / Y Revenue Growth (TTM)
5.13 %
18.57 %
37.02 %
47.55 %
38.96 %
Year on Year Revenue Growth Overall
Ranking
# 782
# 370
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
-2.12 %
-2.27 %
1.82 %
7.94 %
10.4 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2141
# 2098
# 0
# 0
# 0
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Steris Plc's cumulative twelve months Revenue were $ 4,466 millions, company would post below average annual Revenue growth of 10.4% year on year, if the fiscal year would end at Dec 31 2022. A slow-down in the Steris Plc's Revenue growth from the 1112.43% growth in Sep 30 2022.
In the Healthcare sector 137 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 370 to 782.
With the quarterly Revenue reported in the Dec 31 2022 period, Steris Plc's cumulative twelve months Revenue were $ 4,466 millions, company would post below average annual Revenue growth of -73.4% year on year, if the fiscal year would end at Dec 31 2022. A slow-down in the Steris Plc's Revenue growth from the 1112.43% growth in Sep 30 2022.
In the Healthcare sector 137 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 370 to 782.
About Steris Plc Revenue Growth Rates (STE31), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.